OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Toward improved models of human cancer
Bryan E. Welm, Christos Vaklavas, Alana L. Welm
APL Bioengineering (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 8
Bryan E. Welm, Christos Vaklavas, Alana L. Welm
APL Bioengineering (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations
Anthony Letai, Patrick Bhola, Alana L. Welm
Cancer Cell (2021) Vol. 40, Iss. 1, pp. 26-35
Open Access | Times Cited: 180
Anthony Letai, Patrick Bhola, Alana L. Welm
Cancer Cell (2021) Vol. 40, Iss. 1, pp. 26-35
Open Access | Times Cited: 180
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma
Weijia Cai, Mai Q. Nguyen, Nicole A. Wilski, et al.
Cancer Research (2022) Vol. 82, Iss. 14, pp. 2625-2639
Open Access | Times Cited: 13
Weijia Cai, Mai Q. Nguyen, Nicole A. Wilski, et al.
Cancer Research (2022) Vol. 82, Iss. 14, pp. 2625-2639
Open Access | Times Cited: 13
Toward improved models of human cancer: Two perspectives
Roger D. Kamm
APL Bioengineering (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 5
Roger D. Kamm
APL Bioengineering (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 5
Hematogenous metastasis and tumor dormancy as concepts or dogma? The continuum of vessel co-option and angiotropic extravascular migratory metastasis as an alternative
Claire Lugassy, Hynda K. Kleinman, Nathalie Cassoux, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Claire Lugassy, Hynda K. Kleinman, Nathalie Cassoux, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions
Si Zheng, Yufan Ji, Nanxing Li, et al.
Langmuir (2023) Vol. 39, Iss. 49, pp. 18101-18112
Closed Access | Times Cited: 1
Si Zheng, Yufan Ji, Nanxing Li, et al.
Langmuir (2023) Vol. 39, Iss. 49, pp. 18101-18112
Closed Access | Times Cited: 1
Erratum: “Toward improved models of human cancer” [APL Bioeng. 5, 010901 (2021)]
Bryan E. Welm, Christos Vaklavas, Alana L. Welm
APL Bioengineering (2021) Vol. 5, Iss. 2
Open Access | Times Cited: 1
Bryan E. Welm, Christos Vaklavas, Alana L. Welm
APL Bioengineering (2021) Vol. 5, Iss. 2
Open Access | Times Cited: 1
Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer
Edward R. Polanco, Tarek E. Moustafa, Andrew Butterfield, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Edward R. Polanco, Tarek E. Moustafa, Andrew Butterfield, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Editorial Series conclusion and journal outlook
Justin J. Cooper‐White
APL Bioengineering (2022) Vol. 6, Iss. 3
Open Access
Justin J. Cooper‐White
APL Bioengineering (2022) Vol. 6, Iss. 3
Open Access
